Brokerages Set Denali Therapeutics Inc. (NASDAQ:DNLI) Price Target at $37.42
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, thirteen have assigned a buy recommendation and one has given a strong buy recommendation to the […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, thirteen have assigned a buy recommendation and one has given a strong buy recommendation to the […]
